Antonia Sampol
Palma, PM 07120, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Avatrombopag Reduces Platelet Transfusion Requirement in Thrombocytopenia Subsequent to Antineoplastic Therapies in Haematological Patients: The Experience of a Tertiary Centre.
Journal: Journal of clinical medicine
Published: January 12, 2026
Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge.
Journal: Frontiers in pediatrics
Published: December 11, 2025
Multiclonal Profiling of FLT3-ITD in AML Using MinION Sequencing: A Tailored Clustering Approach to Enhance Subclonal Detection.
Journal: OncoTargets and therapy
Published: April 06, 2025
From Clinical Perception to Implicit Bias: Understanding Personality Traits in Lymphoma Patients.
Journal: Cancers
Published: March 31, 2025
High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapy.
Journal: HemaSphere
Published: December 20, 2024
CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases.
Journal: Diagnostic pathology
Published: October 22, 2024
Is t(11;14) Always a Standard-Risk Cytogenetic Abnormality? Results From GEM05MENOS65 and GEM2012 PETHEMA/GEM Transplantation Trials.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 22, 2024
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.
Journal: Blood cancer journal
Published: October 17, 2024
Frequency and Distribution of KIR Genotypes of Donors-Recipient Pairs in the Haploidentical Haematopoietic Stem Cell Transplantation Setting: Collaborative Study by the Spanish Working Group in Histocompatibility and Transplant Immunology (GETHIT) and the Spanish Haematopoietic Transplantation and Cell Therapy Group (GETH-TC).
Journal: HLA
Published: September 18, 2024
Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease.
Journal: Annals of hematology
Published: July 24, 2024
Plasma from patients undergoing allogeneic hematopoietic stem cell transplantation promotes NETOSIS in vitro and correlates with inflammatory parameters and clinical severity.
Journal: Frontiers in immunology
Published: December 09, 2023
Last Updated: 09/26/2026